Fig. 3
From: A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy
Kinetics of Vespula-specific IgG4. a Kinetics of serum Vespula-specific IgG4 measured using commercial ELISA kit at the indicated time-points, in months (averages of individual time-points). N = 23 patients and 20 healthy controls. Statistical significance against baseline time-point was calculated by one-way Anova with Bonferroni post-test (N.S.: > 0.01, *p < 0.01, **p < 0.001). Dashed vertical line separates the VIT course from the follow-up. b Comparison of measurement (O.D.) obtained with the IgG4 commercial kit versus the in-house technique at the indicated time-points, in months (averages of individual time-points). N = 6 patients and five healthy controls. Results are expressed as mean ± SEM